Li Kang Biomedical Co Ltd (6242) — Cash Flow-to-Debt Ratio
Li Kang Biomedical Co Ltd (6242) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of NT$-3.17 Million could theoretically repay 0% of its total liabilities (NT$212.01 Million) in one year. See Li Kang Biomedical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Li Kang Biomedical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Li Kang Biomedical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see 6242 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Li Kang Biomedical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Li Kang Biomedical Co Ltd. Check Li Kang Biomedical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | NT$92.15 Million | NT$221.82 Million | ▲ +14.3% |
| 2024 | 0.36x | NT$65.38 Million | NT$179.93 Million | ▼ -26.0% |
| 2023 | 0.49x | NT$96.74 Million | NT$196.97 Million | ▼ -62.9% |
| 2022 | 1.32x | NT$157.24 Million | NT$118.70 Million | ▲ +171.9% |
| 2021 | 0.49x | NT$60.45 Million | NT$124.07 Million | ▼ -18.6% |
| 2020 | 0.60x | NT$81.67 Million | NT$136.46 Million | ▼ -7.5% |
| 2019 | 0.65x | NT$92.56 Million | NT$143.00 Million | ▼ -12.3% |
| 2018 | 0.74x | NT$105.53 Million | NT$142.93 Million | ▲ +0.4% |
| 2017 | 0.74x | NT$110.61 Million | NT$150.38 Million | ▲ +42.0% |
| 2016 | 0.52x | NT$110.82 Million | NT$213.96 Million | ▲ +99.7% |
| 2015 | 0.26x | NT$63.91 Million | NT$246.44 Million | ▼ -39.7% |
| 2014 | 0.43x | NT$41.66 Million | NT$96.93 Million | ▲ +84.5% |
| 2009 | 0.23x | NT$28.97 Million | NT$124.35 Million | ▲ +1686.7% |
| 2003 | 0.01x | NT$5.63 Million | NT$432.09 Million | ▼ -88.1% |
| 2002 | 0.11x | NT$45.87 Million | NT$418.31 Million | — |